Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Hunkapiller Insider Profile

4 Followers

Michael Hunkapiller, Director at Pacific Biosciences, holds 848.40K shares in Pacific Biosciences (Ticker: PACB).

Michael Hunkapiller's Trading History

PACB
Pacific Biosciences
Mar 02, 2021DirectorUninformative Buy1.49M$1.66M
PACB
Insider Shares: 848.40K (0.44%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 02, 2021Uninformative Sell$7.26M234,246$31.01―
Mar 02, 2021Uninformative Buy$1.49M234,246$6.36―
Feb 26, 2021Uninformative Sell$20.78M605,804$34.29―
Feb 26, 2021Uninformative Buy$3.79M605,804$6.24―
Feb 24, 2021Uninformative Sell$21.99M602,448$36.49―

You May Also Like

Michael Hunkapiller insider profile FAQ

What is the percentage of profitable transactions made by Michael Hunkapiller?
The percentage of profitable transactions made by Michael Hunkapiller is 11%.
What is the average return per transaction made by Michael Hunkapiller?
The average return per transaction made by Michael Hunkapiller is -196.40%.
What stocks does Michael Hunkapiller hold?
Michael Hunkapiller holds: PACB stocks.
What was Michael Hunkapiller’s latest transaction?
Michael Hunkapiller’s latest transaction was an Uninformative Buy of $1.49M.
What was Michael Hunkapiller's most profitable transaction?
Michael Hunkapiller’s most profitable transaction was an Informative Sell of PACB stock on February 20, 2019. The return on the trade was 38.30%.
What is Michael Hunkapiller's role in Pacific Biosciences?
Michael Hunkapiller's role in Pacific Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.